Latest filing published 07 Apr 2026 for NEUROONE MEDICAL TECHNOLOGIES Corp. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Jason Richard Mills appears in our data through filings on NEUROONE MEDICAL TECHNOLOGIES Corp shares, published by SEC (Form 4). Over a trading history stretching from 18 December 2025 to 3 April 2026, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 7 April 2026, the filings show a share grant in NEUROONE MEDICAL TECHNOLOGIES Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations